Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
3.490
-0.250 (-6.68%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Nyxoah Revenue
Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
5.64M EUR
Revenue Growth
+10.96%
P/S Ratio
22.58
Revenue / Employee
30,714 EUR
Employees
184
Market Cap
149.39M USD
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AngioDynamics | 307.31M |
| OraSure Technologies | 115.02M |
| Sanara MedTech | 101.88M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 39.07M |
| Utah Medical Products | 38.52M |
| Stereotaxis | 30.08M |
| Zentek | 687.67K |
NYXH News
- 19 days ago - Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - GlobeNewsWire
- 6 weeks ago - Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewsWire
- 2 months ago - Publication relating to transparency notification - GlobeNewsWire
- 2 months ago - Nyxoah Announces Issuance of First Tranche of Convertible Bonds - GlobeNewsWire
- 2 months ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - GlobeNewsWire
- 3 months ago - Publication relating to transparency notifications - GlobeNewsWire
- 3 months ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - GlobeNewsWire